Natera, Inc.

NASDAQ:NTRA

Medical - Diagnostics & Research

Healthcare
$289.50 +0.98%

+$2.23 today

Market cap
$41.98B
Beta
1.54
P/E (TTM)
-143.0
EPS (TTM)
-$1.60
52W Low $131.81High $256.36

Volume 1.96M

Average 1.41M

NTRA Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Natera, Inc.NASDAQ: NTRA

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q2 FY2026 weighted avg shares of 143.28M shares rose 5.1% year over year, behind the +7.5% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at +11.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +5.1% toward the trailing-twelve-month pace of +7.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
143.28M+1.3% QoQ
Last fiscal yearDec 2025
136.72M+9.6% YoY
LTMJun 2026
139.67M+7.5% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.1%——
1 year+9.6%——
3-year CAGR+11.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
136.72M USD
Year-over-year change
+9.6%
4-year CAGR
+10.8%

Weighted Avg Shares vs competitors

How NTRA compares with its peers on the latest reported figures

  • NTRA's LTM Jun 2026 weighted avg shares of 139.67M shares is the highest of the 8 companies compared; the peer median is 49.71M shares.
  • Its year-over-year change of +7.5% is the 3rd highest of 8, against a peer median of +2.4%.
  • Over three fiscal years its annual growth of +11.6% compares with a peer median of +10.2%.
NTRA Competitors Peer median
Weighted Avg Shares for NTRA and competitors
Company Period LTM YoY 3-year CAGR
NTRANatera, Inc.LTM Jun 2026139.67M +7.5%+11.6%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
VCYTVeracyte, Inc.LTM Jun 202679.27M +2.0%+3.2%
SERASera Prognostics, Inc.LTM Mar 202649.71M +39.7%+15.5%
BLLNBillionToOne, Inc.LTM Jun 202645.72M +2.2%—
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%+0.7%
WGSGeneDx Holdings Corp.LTM Jun 202628.68M +3.5%+38.0%
Peer median (excluding NTRA) 49.71M+2.4%+10.2%

Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue625.49M820.22M1.08B1.7B2.31B
Cost of Revenue318.42M456.26M589.83M673.75M810.63M
Gross Profit307.07M363.97M492.74M1.02B1.5B
Gross Margin49.1%44.4%45.5%60.3%64.8%
Research & Development264.21M316.42M320.68M404.14M624.11M
Selling, General & Admin511.03M588.59M618.31M841.31M1.18B
Operating Expenses775.24M905.01M938.99M1.25B1.81B
Depreciation & Amortization11.25M16.7M24.1M30.97M43.48M
EBITDA(451.54M)(520.8M)(397.8M)(148.08M)(220.54M)
EBITDA Margin-72.2%-63.5%-36.7%-8.7%-9.6%
Operating Income(468.17M)(541.04M)(446.25M)(222.29M)(309.91M)
Operating Margin-74.8%-66.0%-41.2%-13.1%-13.4%
Interest Income5.38M3.54M24.35M43.25M45.89M
Interest Expense8.31M9.32M12.64M10.69M4.07M
Other Income / Expenses(2.92M)(5.78M)11.72M32.56M41.82M
Income Before Tax(471.1M)(546.82M)(434.53M)(189.73M)(268.09M)
Pre-Tax Margin-75.3%-66.7%-40.1%-11.2%-11.6%
Income Tax Expense618K978K271K695K(59.93M)
Net Income(471.72M)(547.8M)(434.8M)(190.43M)(208.16M)
Net Margin-75.4%-66.8%-40.2%-11.2%-9.0%
EPS (Basic)(5.21)(5.57)(3.78)(1.53)(1.52)
EPS (Diluted)(5.21)(5.57)(3.78)(1.53)(1.52)
Weighted Avg Shares90.56M98.41M115M124.72M136.72M
Weighted Avg Shares (Diluted)90.56M98.41M115M124.72M136.72M

Natera, Inc.

NASDAQ:NTRA

Intrinsic Alpha fair value

Locked

Current Price

$289.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.